SUBSCRIBERS
Temasek leads US$85m investment round for gene therapy startup
Published Tue, Feb 26, 2019 · 09:50 PM
Singapore
IMMUNE cell gene therapy startup Gracell Biotechnologies has raised US$85 million through a Series B round led by Singapore government investment firm Temasek Holdings.
Also taking part in the financing round were Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji.
Copyright SPH Media. All rights reserved.
